Harbin Gloria is expected to lose USD0.35–0.38 billion in 2019

On 31 January, Harbin Gloria Pharmaceuticals Co., Ltd. (Harbin Gloria) announced that its net loss in 2019 is expected to be USD0.35–0.38 billion (RMB2.40–2.60 billion). But in 2018, the company's net profit was USD18.18 million (RMB125.8...

Vitamins China E-News 202002

www.cnchemicals.com